Process for continuous purification of single-chain antib...
Martínez Cristancho, Carlos Andrés
During the last years the market for recombinant antibody fragments has been growing very fast. Small-sized fragments can offer new alternatives to the full-length monoclonal antibodies (mAb) in the field of antibody-based therapeutics. Among them, the single-chain antibody fragments (scFv) are the smallest antibody fragments that still possess a complete antigen-binding site. Hence, they are ideal for research, diagnostic and therapy, which r...